Last updated: June 9, 2026
CLINIMIX 4.25/5 Sulfite Free in Dextrose 5% in Plastic Container: Who Supplies It and What Markets Do They Cover?
CliniMix 4.25/5 Sulfite Free in Dextrose 5% in plastic container is supplied in the US market through branded pharmaceutical distribution channels tied to the manufacturer that holds the product’s FDA marketing authorization and labeling. The key commercial question for procurement, formulary contracting, and continuity-of-supply is identifying the FDA-labeled manufacturer and NDC source(s) for each pack size and strength, then mapping those sources to authorized distributors and typical wholesaler channels.
Primary procurement reality: “Supplier” can mean (1) the FDA-labeled drug manufacturer tied to the NDC(s), (2) wholesalers/distributors carrying the product, and (3) contract manufacturing supply chain. Without the exact NDC and pack size, the labeled manufacturer and sourcing chain can’t be mapped to a definitive list of suppliers.
Which company manufactures CLINIMIX 4.25/5 sulfite free in dextrose 5% plastic container?
Featured snippet answer: The manufacturer is the company listed as the applicant/manufacturer on the FDA drug label for the specific NDC corresponding to “CliniMix 4.25/5 Sulfite Free in Dextrose 5% in plastic container.”
Because “CliniMix 4.25/5 sulfite free in dextrose 5%” exists across multiple presentations (volumes, pack sizes) that map to different NDCs, the manufacturer can appear different across NDCs even when the clinical product name is consistent. The supplier list therefore must be NDC-specific.
How to identify the labeled manufacturer for each presentation
- Pull the US label for the exact presentation (plastic container, sulfite-free, dextrose 5%).
- Record:
- NDC
- labeled manufacturer/applicant
- pack size/volume
- storage and preparation instructions (can help validate you selected the correct presentation)
Why NDC specificity matters
- Wholesaler shelves are NDC-driven.
- Contract supply allocations for IV nutrition products commonly vary by presentation and lot.
- Substitution in procurement is governed by the exact NDC match under typical hospital purchasing policies.
What suppliers distribute CLINIMIX 4.25/5 plastic container in the US?
Featured snippet answer: Distributors are typically national drug wholesalers that carry NDC-aligned product inventory, but the exact distributor roster varies by institution and contracted GPO/wholesaler.
For procurement planning, the “supplier list” in practice usually includes:
- McKesson (wholesale distribution)
- Cardinal Health (wholesale distribution)
- AmerisourceBergen / Cencora (wholesale distribution)
- Regional wholesalers that supply institutions through non-GPO contracts
These distributors do not necessarily hold product manufacturing rights; they are channel suppliers. The definitive supplier mapping still depends on NDC availability and confirmed product receipt.
Procurement-driven supplier mapping (what matters operationally)
- Contracted wholesaler(s) for the hospital or IDN
- Ability to maintain supply during nutrition-IV shortages
- Lot tracking and recalls for the exact NDC/strength/container configuration
Does CLINIMIX 4.25/5 sulfite free have multiple suppliers or single-source manufacturing?
Featured snippet answer: Most branded IV nutrition products in the US are single-source at the FDA-labeled manufacturer level, with inventory flowing through multiple distributors. Multiple suppliers typically appear only when:
- different NDC presentations are manufactured by different sites, or
- temporary supply is redirected to an alternate manufacturing site under regulatory approval.
Where multiple “suppliers” typically show up
- Alternate manufacturing site under the same marketing authorization
- Split distribution sourcing by wholesaler
- Temporary supply during constrained manufacturing capacity
What is the FDA status of CLINIMIX 4.25/5 sulfite free in dextrose 5%?
Featured snippet answer: As an IV nutrition product, CLINIMIX is marketed as an FDA-approved drug product with listed labeling for compounding/administration instructions. The relevant status for exclusivity and substitution is determined by the NDC’s FDA label and any corresponding Orange Book listing (if applicable).
Orange Book relevance for this product
For many IV multi-nutrient solutions, patent status does not always map cleanly to Orange Book “drug product” listings in the way small molecules do, but the product’s:
- NDA marketing authorization status
- any listed patents (process, composition, packaging, methods)
- exclusivity or blocking periods
still must be checked per NDC.
When does supply change or risk increase for CLINIMIX 4.25/5 sulfite free?
Featured snippet answer: Supply risk tends to increase when there are:
- manufacturing capacity constraints at the labeled manufacturer site,
- container supply disruptions (plastic container availability),
- raw material constraints for dextrose and amino acid fractions,
- or broader IV nutrition shortages affecting multiple brands.
What procurement teams monitor
- Lot-level availability by NDC and container size
- Distributor backorders and substitution rules
- FDA recall notices affecting the same NDC presentation
How should hospitals qualify suppliers for CLINIMIX 4.25/5?
Featured snippet answer: Qualify suppliers by:
- NDC match (presentation, sulfite-free, dextrose concentration, container type)
- ability to provide consistent lot traceability
- response time for resupply during backorders
Supplier qualification checklist (high-signal)
- Confirm the distributor can supply the exact NDC for the required container size.
- Require delivery documentation showing NDC and lot number.
- Check historical lead times and backorder frequency for that NDC.
Key Takeaways
- “Supplier” for CLINIMIX 4.25/5 sulfite free in dextrose 5% plastic container must be defined as either the FDA-labeled manufacturer or the channel distributor(s) carrying the NDC.
- Distributor availability is usually dominated by major US wholesalers, but the only reliable source-to-NDC mapping comes from the exact NDC for your presentation.
- Procurement and continuity planning should be NDC-specific with lot traceability and historical backorder performance.
FAQs
-
Which NDC corresponds to CLINIMIX 4.25/5 sulfite free in dextrose 5% plastic container?
NDCs vary by pack size and volume; the correct NDC must match the exact labeled presentation.
-
Can hospitals substitute another CLINIMIX formulation for the sulfite-free dextrose 5% version?
Substitution depends on NDC equivalence and clinical equivalence; procurement rules generally require exact NDC match or explicit therapeutic interchange approval.
-
Who are the typical wholesale distributors that stock CLINIMIX IV nutrition products?
Large national wholesalers like McKesson, Cencora, and Cardinal Health are common, with exact availability by NDC.
-
Does CLINIMIX have generic competition for CLINIMIX 4.25/5 sulfite free?
Generic competition depends on whether approved equivalents exist for the exact presentation and whether any related patents or exclusivity block entry.
-
What supply risks affect IV nutrition products like CLINIMIX?
Capacity constraints, container supply issues, raw material availability, and broader IV nutrition shortages drive backorders by NDC.
References
- FDA. Drug Label Information and NDC-based product labeling (access via the FDA drug label/NDC lookup tools).
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (NDC and NDA search).
- CDRH/CBER/FDA safety communications. FDA drug recalls and safety alerts relevant to IV nutrition products (search by product name and NDC).
